Insider Stock Trading History of Buchi J Kevin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Buchi J Kevin since year 2005. The trader's CIK number is 1209726. At the time of this reporting, Buchi J Kevin is the President & CEO of Tetralogic Pharmaceuticals Corp . (stock ticker symbol TLOG). See this page for all insider trading activities at Tetralogic Pharmaceuticals Corp .

Note that in the past BUCHI J KEVIN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Buchi J Kevin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-03-26 TLOG Tetralogic Pharmaceuticals Corp Buy 5,000 4.23 21,150
2015-01-07 TLOG Tetralogic Pharmaceuticals Corp Buy 5,000 5.04 25,179
2014-12-09 TLOG Tetralogic Pharmaceuticals Corp Buy 5,000 6.01 30,059
2014-12-02 TLOG Tetralogic Pharmaceuticals Corp Buy 10,000 4.99 49,900
2014-11-18 TLOG Tetralogic Pharmaceuticals Corp Buy 10,000 4.82 48,190
2014-11-11 TLOG Tetralogic Pharmaceuticals Corp Buy 10,000 3.93 39,330
2013-12-17 TLOG Tetralogic Pharmaceuticals Corp Buy 285,714 7.00 1,999,998
2013-01-29 STML Stemline Therapeutics Inc Buy 500 10.00 5,000
2006-02-17 CEPH Cephalon Inc Sale 28,684 74.40 2,134,089
2010-03-05 CEPH Cephalon Inc Option Ex 30,000 51.12 1,533,750
2010-03-05 CEPH Cephalon Inc Sale 30,000 70.64 2,119,200
2008-12-03 CEPH Cephalon Inc Sale 15,000 74.28 1,114,200
2007-12-06 CEPH Cephalon Inc Sale 20,000 76.00 1,520,060
2006-02-17 CEPH Cephalon Inc Option Ex 29,073 15.33 445,776
2006-02-17 CEPH Cephalon Inc Sale 29,073 74.40 2,163,118

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Buchi J Kevin (President & CEO of Tetralogic Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.